| |
We are looking forward to hosting you for the 22nd international congress of the European Society of Toxicology In Vitro (ESTIV2024), taking place 3 – 6 June 2024 in Prague, Czech Republic.
The online abstract submission module is open for only 3 more days and can be found here including detailed instructions. Last Chance Late-Breaking Abstract Submission Deadline: 15 March 2024, 11:59 pm. The ESTIV2024 congress will be held in the Cubex Centre in Prague. With its rich cultural heritage, breathtaking architecture, and historical charm, Prague offers the perfect backdrop for ESTIV2024. Immerse yourself in the vibrant atmosphere of this captivating city while connecting with peers, forging new collaborations, and building lasting professional relationships.
The general theme of the congress is “Applications of NAMs in Drug Discovery and Drug and Chemical Safety Assessment”.
Your input on the program is important to us and we invite you to submit an abstract for the congress.
Abstracts can be submitted within the following topics:
- Bio-engineering, stem cells and disease models
- Models, biomarkers and assays for endocrine disruption
- Models, biomarkers and assays for systemic and immune toxicity
- Models, biomarkers and assays for developmental toxicity
- Cardiotoxicity and cardiac efficacy models
- Local toxicity testing (safety and efficacy)
- Case studies for successful use and implementation of complex in vitro models
- Challenges in cosmetics safety
- Organ-on-a-chip & Microphysiological Systems
- Regulatory considerations for complex NAMs
- Computational toxicology – in silico modelling, read-across, artificial intelligence and machine learning
- Toxicokinetics and in vitro – in vivo extrapolation
- In vitro systems to assess respiratory toxicity
- Non-animal methods for safety testing of biopharmaceuticals/biotherapies/vaccines
- Knowledge sharing and education
- Funding the development, validation and implementation of NAMs
- ECHA, EMA and EFSA perspectives on the use of NAMs
- In vitro and in silico methods for safety assessment of medical devices
- Role of 3R centres in the dissemination and implementation of NAMs
- Other
We look forward to your input. Do not hesitate to get in touch with ideas, suggestions, comments or questions you might have regarding the congress, its programme or its organisation.
Looking forward seeing you all in 2024 at ESTIV2024 Congress in Prague.
On behalf of the Local Organising Committee,
Helena Kandarova, President of ESTIV
Clive Roper, Vice President of ESTIV
|
|
